首页> 外文期刊>Nature Communications >The switching role of beta-adrenergic receptor signalling in cell survival or death decision of cardiomyocytes
【24h】

The switching role of beta-adrenergic receptor signalling in cell survival or death decision of cardiomyocytes

机译:β-肾上腺素能受体信号在心肌细胞存活或死亡决定中的转换作用

获取原文
获取原文并翻译 | 示例
           

摘要

How cell fate (survival or death) is determined and whether such determination depends on the strength of stimulation has remained unclear. In this study, we discover that the cell fate of cardiomyocytes switches from survival to death with the increase of beta-adrenergic receptor (beta-AR) stimulation. Mathematical simulations combined with biochemical experimentation of beta-AR signalling pathways show that the gradual increment of isoproterenol (a non-selective beta 1/beta 2-AR agonist) induces the switching response of Bcl-2 expression from the initial increase followed by a decrease below its basal level. The ERK1/2 and ICER-mediated feed-forward loop is the hidden design principle underlying such cell fate switching characteristics. Moreover, we find that beta 1-blocker treatment increases the survival effect of beta-AR stimuli through the regulation of Bcl-2 expression leading to the resistance to cell death, providing new insight into the mechanism of therapeutic effects. Our systems analysis further suggests a novel potential therapeutic strategy for heart disease.
机译:如何确定细胞命运(存活还是死亡)以及这种决定是否取决于刺激强度尚不清楚。在这项研究中,我们发现,随着β-肾上腺素能受体(β-AR)刺激的增加,心肌细胞的命运从生存转为死亡。数学模拟与β-AR信号通路的生化实验相结合表明,异丙肾上腺素(非选择性β1 /β2 -AR激动剂)的逐渐增加会诱导Bcl-2表达从最初的增加到减少的转换反应低于其基础水平。 ERK1 / 2和ICER介导的前馈环是这种细胞命运切换特性的隐藏设计原理。此外,我们发现,β1受体阻滞剂治疗通过调节Bcl-2表达导致细胞死亡抵抗而增加了β-AR刺激的存活率,从而为治疗作用的机理提供了新见识。我们的系统分析进一步提出了一种针对心脏病的新型潜在治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号